Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Dec 16:11:1530705.
doi: 10.3389/fcvm.2024.1530705. eCollection 2024.

Editorial: Cardiovascular complications of emerging oncological therapies

Isaac Ho  1 , Yee-Tat Lee  2 , Tsun-Ho Lam  2 , Chun-Ka Wong  2
Affiliations
Editorial

Editorial: Cardiovascular complications of emerging oncological therapies

Isaac Ho et al. Front Cardiovasc Med. .
No abstract available

Keywords: cardio-oncology; cardiovascular adverse event; hypertension; immune checkpoint inhibitor; myocarditis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Cardiovascular complications of emerging oncological therapies

References

    1. Lam T-H, Wong JS-L, Wong C-K, Kwok GGW, Zhow M, So BY-F, et al. From bad to worse: the clinical Spectrum of immune checkpoint inhibitor myocarditis and associated 3M syndrome with concomitant myositis and myasthenia. J Hong Kong Coll Cardiol. (2022) 29(3):135–42. 10.55503/2790-6744.1484 - DOI
    1. Chang CY, Park H, Malone DC, Wang CY, Wilson DL, Yeh YM, et al. Immune checkpoint inhibitors and immune-related adverse events in patients with advanced melanoma: a systematic review and network meta-analysis. JAMA Netw Open. (2020) 3(3):e201611. 10.1001/jamanetworkopen.2020.1611 - DOI - PMC - PubMed
    1. Zhu H, Galdos FX, Lee D, Waliany S, Huang YV, Ryan J, et al. Identification of pathogenic immune cell subsets associated with checkpoint inhibitor-induced myocarditis. Circulation. (2022) 146(4):316–35. 10.1161/CIRCULATIONAHA.121.056730 - DOI - PMC - PubMed
    1. Wong CK, Lam TH, Liao SY, Lau YM, Tse HF, So BYF. Immunopathogenesis of immune checkpoint inhibitor induced myocarditis: insights from experimental models and treatment implications. Biomedicines. (2023) 11(1):107. 10.3390/biomedicines11010107 - DOI - PMC - PubMed
    1. Nielsen DL, Juhl CB, Nielsen OH, Chen IM, Herrmann J. Immune checkpoint inhibitor-induced cardiotoxicity: a systematic review and meta-analysis. JAMA Oncol. (2024) 10(10):1390–9. 10.1001/jamaoncol.2024.3065 - DOI - PMC - PubMed

Publication types

LinkOut - more resources